Technology | October 21, 2013

Medtronic Launches Device to Remove Coronary Thrombus

thrombectomy devices cath lab aspiration catheter medtronic export advance

October 21, 2013 — Medtronic Inc. announced the U.S. launch of the Export Advance aspiration catheter, a U.S. Food and Drug Administration (FDA)-cleared catheter that features a pre-loaded stylet that increases deliverability and kink resistance while traversing the vasculature to reach the aspiration site.

The Export Advance aspiration catheter is also constructed with full-wall variable braiding technology, which provides variable degrees of stiffness along the length of the device to enhance flexibility and pushability while navigating the device through the vasculature.

The catheter received CE mark in May and has been introduced in various international markets since then. It is the latest addition to Medtronic’s portfolio of thrombectomy devices, which also includes the Export AP aspiration catheter.

For more information: www.medtronic.com


Related Content

News | Thrombectomy Devices

Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...

Home January 19, 2026
Home
News | Thrombectomy Devices

Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...

Home January 07, 2026
Home
News | Thrombectomy Devices

Dec. 16, 2025 — A new study, published in the American Journal of Cardiology, found that the use of Computer Assisted ...

Home December 23, 2025
Home
News | Thrombectomy Devices

Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...

Home November 07, 2025
Home
News | Thrombectomy Devices

Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...

Home October 27, 2025
Home
News | Thrombectomy Devices

Sept. 2, 2025 — Imperative Care, Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ...

Home September 02, 2025
Home
News | Thrombectomy Devices

June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...

Home June 16, 2025
Home
News | Thrombectomy Devices

March 24, 2025 — Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home March 24, 2025
Home
News | Thrombectomy Devices

Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous ...

Home January 30, 2025
Home
News | Thrombectomy Devices

Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...

Home November 07, 2024
Home
Subscribe Now